Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs HRTS overlap: 57% of top holdings shared

Bottom line

How much do XLV and HRTS overlap?

57% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 69.8% of XLV's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVHRTS
Weight overlap (top 25)57%
Shared holdings15
Weight in shared holdings69.8%51.9%
Total positions6545
Expense ratio0.08%0.75%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings XLV and HRTS have in common

Holding% of XLV% of HRTSOverlap
Eli Lilly & Co16.51%11.52%11.52%
Johnson & Johnson10.64%3.59%3.59%
AbbVie Inc7.74%2.40%2.40%
UnitedHealth Group Inc6.57%5.24%5.24%
Merck & Co Inc5.52%4.27%4.27%
Amgen Inc3.40%1.91%1.91%
Thermo Fisher Scientific Inc3.24%3.97%3.24%
Abbott Laboratories2.75%2.61%2.61%
Gilead Sciences Inc2.73%3.43%2.73%
Vertex Pharmaceuticals Inc2.19%2.93%2.19%
Danaher Corp2.09%2.66%2.09%
Bristol-Myers Squibb Co2.05%2.09%2.05%
Medtronic PLC1.75%1.88%1.75%
McKesson Corp1.58%1.71%1.58%
Regeneron Pharmaceuticals Inc1.08%1.67%1.08%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Intuitive Surgical Inc — 2.45%
  2. Pfizer Inc — 2.39%
  3. CVS Health Corp — 2.30%
  4. Stryker Corp — 1.89%
  5. Elevance Health Inc — 1.46%
  6. Cigna Group/The — 1.27%
  7. Boston Scientific Corp — 1.10%
  8. HCA Healthcare Inc — 1.05%
  9. Cardinal Health Inc — 0.97%
  10. Cencora Inc — 0.96%

Only in HRTS

  1. Novo Nordisk A/S — 5.24%
  2. Roche Holding AG — 4.50%
  3. AstraZeneca PLC — 4.00%
  4. Novartis AG — 3.38%
  5. Revolution Medicines Inc — 3.33%
  6. Bridgebio Pharma Inc — 2.59%
  7. Cytokinetics Inc — 2.52%
  8. Teva Pharmaceutical Industries — 2.06%
  9. Dexcom Inc — 1.92%
  10. Edwards Lifesciences Corp — 1.75%

Asset mix

Asset typeXLVHRTS
Stocks99.7%99.2%
Cash & short-term funds0.3%0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryXLVHRTS
US97.9%74.9%
CH—7.9%
DK—7.0%
GB—4.0%
IE2.1%1.9%
IL—2.1%
JP—1.3%
CA—0.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do XLV and HRTS overlap?
About 57% by weight. 15 securities appear in both funds' top 25 holdings; they make up 69.8% of XLV's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and HRTS have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Merck & Co Inc, Johnson & Johnson, Thermo Fisher Scientific Inc.
Should I own both XLV and HRTS?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or HRTS?
XLV is broader, with 65 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.